Skip to main content

Table 2 Microbiology of carbapenem-resistant Enterobacteriaceae isolate by type of infection

From: Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals

Pathogen

VABP (n = 31) n (%)

Bacteremia (n = 22) n (%)

cUTI/AP (n = 18) n (%)

HABP (n = 16) n (%)

SWI (n = 16) n (%)

BTI (n = 9) n (%)

DWI (n = 7) n (%)

SBFI (n = 5) n (%)

All (n = 124) n (%)

Klebsiella pneumoniae

27 (87.1%)

18 (81.8%)

10 (55.6%)

11 (68.8%)

3 (18.8%)

4 (44.4%)

6 (85.7%)

5 (100%)

84 (67.7%)

Enterobacter cloacae

3 (9.7%)

2 (9.1%)

3 (16.7%)

2 (12.5%)

10 (62.5%)

4 (44.4%)

0

0

24 (19.4%)

Escherichia coli

0

2 (9.1%)

5 (27.8%)

2 (12.5%)

1 (6.3%)

0

0

0

10 (8.1%)

Klebsiella oxytoca

1 (3.2%)

0

0

1 (6.3%)

2 (12.5%)

1 (11.1%)

1 (14.3%)

0

6 (4.8%)

  1. AP acute pyelonephritis, BTI biliary tract infection, cUTI complicated urinary tract infection, DWI deep wound infection, HABP hospital-acquired bacterial pneumonia, SBFI sterile body fluids infection, SWI superficial wound infection, VABP ventilator-associated bacterial pneumonia